Literature DB >> 31776938

BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Bo Wang1,2, Chen Cao3, Xi Liu4, Xin He5, Hao Zhuang6, Dong Wang7, Budong Chen8.   

Abstract

PURPOSE: BRCA1-associated protein (BRAP) was first identified by its ability to bind to the nuclear localization signalling motif of BRCA1 and other proteins. Subsequently, human BRAP has been found to exert multiple functions, many of which are related to cancer development. Up till now, however, the role of BRAP in glioma development has remained obscure. Here, we report a role for BRAP in mediating the proliferation and migration of glioma cells both in vitro and in vivo.
METHODS: The expression of BRAP in 98 glioma patient samples was determined by immunohistochemistry, after which associations between BRAP expression and patient prognosis were assessed. A short hairpin RNA (shRNA) was used to knock down BRAP and an expression vector was used to exogenously overexpress BRAP in glioma cells. The effects of BRAP expression on tumour cell behaviour in vitro and in an in vivo xenograft mouse model were examined.
RESULTS: We found that in glioma patients BRAP expression was associated with a favourable prognosis. We also found that shRNA-mediated knockdown of BRAP facilitated the proliferation and migration of glioma cells and the self-renewal of glioma stem cells. In parallel, we found that BRAP knockdown increased tumour growth and invasion and decreased survival in an in vivo glioma xenograft mouse model. Mechanistically, we found that BRAP inhibited glioma cell proliferation and migration, as well as glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.
CONCLUSIONS: Together, our findings identify BRAP as a mediator of glioma cell proliferation, migration and glioma stem cell self-renewal.

Entities:  

Keywords:  BRAP; Cancer stem cells; Glioma; mTOR

Year:  2019        PMID: 31776938     DOI: 10.1007/s13402-019-00482-8

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  36 in total

1.  Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.

Authors:  Diana Matias; Joana Balça-Silva; Luiz Gustavo Dubois; Bruno Pontes; Valéria Pereira Ferrer; Luciane Rosário; Anália do Carmo; Juliana Echevarria-Lima; Ana Bela Sarmento-Ribeiro; Maria Celeste Lopes; Vivaldo Moura-Neto
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

2.  High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Stupp; M Brada; M J van den Bent; J-C Tonn; G Pentheroudakis
Journal:  Ann Oncol       Date:  2014-04-29       Impact factor: 32.976

3.  BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.

Authors:  Yanjie Zhao; Lixuan Wei; Mingming Shao; Xudong Huang; Jiang Chang; Jian Zheng; Jiahui Chu; Qionghua Cui; Linna Peng; Yingying Luo; Wenle Tan; Wen Tan; Dongxin Lin; Chen Wu
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

Review 4.  Epidemiology of Brain Tumors.

Authors:  Katharine A McNeill
Journal:  Neurol Clin       Date:  2016-11       Impact factor: 3.806

5.  Crosstalk between M2 macrophages and glioma stem cells.

Authors:  Leora M Nusblat; Molly J Carroll; Charles M Roth
Journal:  Cell Oncol (Dordr)       Date:  2017-06-22       Impact factor: 6.730

6.  Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Authors:  Fredrick R Schumacher; Stephanie L Schmit; Shuo Jiao; Christopher K Edlund; Hansong Wang; Ben Zhang; Li Hsu; Shu-Chen Huang; Christopher P Fischer; John F Harju; Gregory E Idos; Flavio Lejbkowicz; Frank J Manion; Kevin McDonnell; Caroline E McNeil; Marilena Melas; Hedy S Rennert; Wei Shi; Duncan C Thomas; David J Van Den Berg; Carolyn M Hutter; Aaron K Aragaki; Katja Butterbach; Bette J Caan; Christopher S Carlson; Stephen J Chanock; Keith R Curtis; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Stephanie M Gogarten; Richard B Hayes; Brian Henderson; David J Hunter; Rebecca D Jackson; Laurence N Kolonel; Charles Kooperberg; Sébastien Küry; Andrea LaCroix; Cathy C Laurie; Cecelia A Laurie; Mathieu Lemire; David Levine; Jing Ma; Karen W Makar; Conghui Qu; Darin Taverna; Cornelia M Ulrich; Kana Wu; Suminori Kono; Dee W West; Sonja I Berndt; Stéphane Bezieau; Hermann Brenner; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Gerhard A Coetzee; David V Conti; David Duggan; Jane C Figueiredo; Barbara K Fortini; Steven J Gallinger; W James Gauderman; Graham Giles; Roger Green; Robert Haile; Tabitha A Harrison; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Eric Jacobs; Motoki Iwasaki; Sun Ha Jee; Mark Jenkins; Wei-Hua Jia; Amit Joshi; Li Li; Noralene M Lindor; Keitaro Matsuo; Victor Moreno; Bhramar Mukherjee; Polly A Newcomb; John D Potter; Leon Raskin; Gad Rennert; Stephanie Rosse; Gianluca Severi; Robert E Schoen; Daniela Seminara; Xiao-Ou Shu; Martha L Slattery; Shoichiro Tsugane; Emily White; Yong-Bing Xiang; Brent W Zanke; Wei Zheng; Loic Le Marchand; Graham Casey; Stephen B Gruber; Ulrike Peters
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

Review 7.  Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer.

Authors:  Long Zhang; Fangfang Zhou; Peter ten Dijke
Journal:  Trends Biochem Sci       Date:  2013-11-14       Impact factor: 13.807

8.  The single nucleotide polymorphisms in BRAP decrease the risk of metabolic syndrome in a Chinese young adult population.

Authors:  Lijun Wu; Bo Xi; Dongqing Hou; Xiaoyuan Zhao; Junting Liu; Hong Cheng; Yue Shen; Xingyu Wang; Jie Mi
Journal:  Diab Vasc Dis Res       Date:  2012-09-10       Impact factor: 3.291

9.  The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal.

Authors:  Alex J Fulcher; Daniela M Roth; Shadma Fatima; Gualtiero Alvisi; David A Jans
Journal:  FASEB J       Date:  2009-12-29       Impact factor: 5.191

10.  SNPs in BRAP associated with risk of myocardial infarction in Asian populations.

Authors:  Kouichi Ozaki; Hiroshi Sato; Katsumi Inoue; Tatsuhiko Tsunoda; Yasuhiko Sakata; Hiroya Mizuno; Tsung-Hsien Lin; Yoshinari Miyamoto; Asako Aoki; Yoshihiro Onouchi; Sheng-Hsiung Sheu; Shiro Ikegawa; Keita Odashiro; Masakiyo Nobuyoshi; Suh-Hang H Juo; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

View more
  6 in total

1.  MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway.

Authors:  Chensheng Qiu; Weiliang Su; Nana Shen; Xiaoying Qi; Xiaolin Wu; Kai Wang; Lin Li; Zhu Guo; Hao Tao; Guanrong Wang; Bohua Chen; Hongfei Xiang
Journal:  BMC Cancer       Date:  2020-12-03       Impact factor: 4.430

2.  MARCH6 promotes Papillary Thyroid Cancer development by destabilizing DHX9.

Authors:  Yang Liu; Siyuan Xu; Ying Huang; Shaoyan Liu; Zhengang Xu; Minghui Wei; Jie Liu
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

3.  CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.

Authors:  Le Wang; Bingcheng Ren; Hao Zhuang; Yue Zhong; Yang Nan
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

4.  Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation.

Authors:  Yifan Zhang; Xvlei Hu; Hailiang Li; Jian Yao; Ping Yang; Yuanxiang Lan; Hechun Xia
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway.

Authors:  Qingqiang Dai; Tianqi Zhang; Chen Li
Journal:  Cancer Manag Res       Date:  2020-03-13       Impact factor: 3.989

6.  Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.

Authors:  Xiaolan You; Jian Wu; Xiaojun Zhao; Xingyu Jiang; Wenxuan Tao; Zhiyi Chen; Chuanjiang Huang; Tingrui Zheng; Xianhe Shen
Journal:  Aging (Albany NY)       Date:  2021-07-14       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.